For emerging medical device companies, bringing an innovative product to market is a major achievement. Years of research, development, clinical testing, and regulatory preparation can lead to a successful commercial launch.
But as a medical device company grows, so does its exposure to risks that many founders and executives underestimate.
A product malfunction, patient injury, clinical trial incident, or intellectual property dispute can create significant financial and legal challenges—even when a company has taken reasonable precautions.
Here’s a scenario:
Your company develops an innovative medical device, secures the necessary regulatory clearance, and begins distributing it to healthcare providers.
Several months later, a patient experiences a serious complication allegedly connected to your device. A lawsuit follows, naming your company, its executives, and potentially other parties involved in manufacturing or distribution.
Is Your Medical Device Company Financially Prepared to Respond?
Understanding Medical Device Liability Risks
Medical device manufacturers and developers face exposures that differ significantly from those of traditional businesses.
Depending on the products they develop and their stage of commercialization, these companies may face:
- Product liability claims involving alleged device defects, malfunctions, or patient injuries.
- Clinical trial liability arising from injuries or adverse events during human studies.
- Intellectual property disputes involving patents, proprietary technologies, or licensing agreements.
- Product recalls that create substantial expenses and interrupt business operations.
- Cybersecurity and data privacy risks associated with connected medical devices and digital health platforms.
- Directors and officers liability involving allegations of mismanagement, inadequate disclosures, or failures in corporate oversight.
For an emerging medical device company, even defending an allegation that ultimately proves unfounded can require substantial financial resources.
Does Your Existing Insurance Actually Cover These Risks?
Many medical device companies assume their general liability insurance provides adequate protection.
Unfortunately, medical device exposures often require more specialized coverage.
Depending on the company’s operations, product development stage, and contractual obligations, an insurance program may need to include:
- Medical Device Product Liability Insurance: Protection against covered claims involving bodily injury or property damage allegedly caused by medical devices.
- Clinical Trial Insurance: Coverage for certain liabilities arising from clinical research involving human participants.
- Product Recall Insurance: Financial protection for specified recall-related expenses, subject to policy terms and exclusions.
- Errors & Omissions (E&O) Insurance: Coverage for certain claims arising from professional services, technology failures, or errors, depending on the policy.
- Directors & Officers (D&O) Insurance: Protection for covered management liability claims involving company leadership.
- Cyber Liability Insurance: Coverage addressing specified cybersecurity incidents, data breaches, and related liabilities.
Not every policy covers every exposure. Intellectual property infringement, contractual indemnification, product recall expenses, and clinical trial activities may require separate consideration.
The important question isn’t simply whether your company has insurance.
It’s whether the coverage reflects the risks associated with your specific medical device, operations, and business relationships.
Why Insurance Needs Change as Medical Device Companies Grow
A medical device startup preparing for its first clinical trial faces a different risk profile than a company manufacturing and distributing products internationally.
As a business progresses through development, clinical testing, regulatory clearance, commercialization, and expansion, its insurance requirements can change substantially.
New risks may emerge when a company:
- Begins clinical trials or expands research activities.
- Enters manufacturing or distribution agreements.
- Licenses proprietary medical technology.
- Launches products in new markets.
- Raises venture capital or adds outside board members.
- Establishes partnerships with hospitals or healthcare systems.
These milestones should trigger a review of insurance coverage, contractual obligations, and potential financial exposure.
Insurance should evolve alongside the business—not remain unchanged as the company’s risks become more complex.
Protect Your Medical Device Company Before a Claim Happens
For medical device founders, executives, boards, and investors, insurance and risk management should be part of the commercialization strategy from the beginning.
At KEH Insurance Agency, I work with emerging and growth-stage companies to understand their technologies, business models, contractual relationships, and potential liabilities.
My goal is to help companies identify coverage gaps, evaluate specialized insurance solutions, and build protection appropriate for their stage of development.
Whether your company is preparing for clinical trials, approaching commercialization, manufacturing medical devices, or expanding into new markets, I’d be happy to discuss ways to strengthen your insurance and risk management strategy.
The right time to understand your insurance exposure is before a claim puts your company’s future at risk.
Steven Kantor
Executive Vice President | KEH Insurance Agency
Emerging & Growth-Stage Companies | Risk Management & Insurance Advisory
Contact: skantor@keh4ins.com
Website: https://steven-kantor.com/